Browse AMR Genes
Explore antimicrobial resistance genes from the literature
Explore antimicrobial resistance genes from the literature
beta-lactamase
Overview
| Allele | Database | Papers | Drug Classes | Organisms | Countries | Years | Sequence Accession | Protein Accession |
|---|---|---|---|---|---|---|---|---|
| blaCMY-8 | Reslit | 1 | cefotaxime, cefoxitin | Klebsiella pneumoniae | Taiwan | 2000 | AF167990 | - |
| blaMOX-2 | Reslit | 1 |
| cefepime, cefoxitin +2 |
| Klebsiella pneumoniae +1 |
| Greece |
| 2002 |
| AJ276453 |
| - |
| blaCMY-9 | Reslit | 1 | ceftazidime, cefotaxime +1 | Escherichia coli | Japan | 2002 | AB061794 | - |
Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan.
The study identifies SHV-12 as a prevalent extended-spectrum beta-lactamase in Klebsiella pneumoniae isolates and characterizes a novel AmpC beta-lactamase, CMY-8, which confers resistance to cephalosporins and cephamycins.
Novel plasmid-encoded class C beta-lactamase (MOX-2) in Klebsiella pneumoniae from Greece.
The study identifies a novel plasmid-encoded class C beta-lactamase, MOX-2, in a multidrug-resistant Klebsiella pneumoniae isolate from Greece, which exhibits high hydrolytic activity against various beta-lactam antibiotics.
Characterization of a novel plasmid-mediated cephalosporinase (CMY-9) and its genetic environment in an Escherichia coli clinical isolate.
The study identifies a novel plasmid-mediated cephalosporinase, CMY-9, which confers resistance to several β-lactam antibiotics, including ceftazidime, cefpirome, cefotaxime, cefminox, cefoxitin, and moxalactam. The gene was cloned and characterized in E. coli.
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research